Abstract
Cosmetic treatments have become increasingly popular over the past decade with the advent of new techniques and devices, such as lasers. According to recent statistics released by the American Society for Aesthetic Plastic Surgery (ASAPS), there were nearly 11.5 million surgical and nonsurgical cosmetic procedures performed in the United States in 2006. The majority were nonsurgical with over 2.2 million laser procedures performed for hair removal, skin resurfacing and treatment of leg veins. Approximately 93% of laser skin resurfacing procedures were performed with non ablative techniques.1
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
The American Society for Aesthetic Plastic Surgery. Cosmetic surgery national data bank page. Available at: http://www.surgery.org/download/2006stats.pdf. Accessed November 30, 2007.
Sarwer D, Crerand C. Body image and cosmetic medical treatments. Body Image. 2004;1:99-111.
Edgerton M, Jacobson W, Meyer E. Surgical-psychiatric study of patients seeking plastic (cosmetic) surgery: ninety-eight consecutive patients with minimal deformity. Br J Plast Surg. 1960;13:136-145.
Rankin M, Borah G. National plastic surgical nursing survey. Plast Surg Nurs. 2006;26(4):178-183.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American PsychiaÂtric Association; 2000.
Phillips K, Dufresne RJ. Body dysmorphic disorder: a guide for primary care physicians. Prim Care. 2002;29:99-111.
Phillips K. The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. New York: Oxford University Press; 1996.
Phillips K. Body dysmorphic disorder and depression: theoretical considerations and treatment strategies. Psychiatr Q. 1999;70(4):313-331.
Rief W, Buhlmann U, Wilhelm S, Borkenhagen A, Brahler E. The prevalence of body dysmorphic disorder: a population based survey. Psychol Med. 2006;36(6):877-885.
Castle DJ, Phillips KA, eds. Disorders of Body Image. Hampshire: Wrightson Biomedical; 2002.
Vulink N, Sigurdsson V, Kon M, Bruijnzeel-Koomen C, Westenberg H, Denys D. Body dysmorphic disorder in 3-8% of patients in outpatient dermatology and plastic surgery clinics. Ned Tijdschr Geneeskd. 2006;150(2):97-100.
Phillips K, Dufresne RJ, Wilkel C, Vittorio C. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol. 2000;42:436-441.
Phillips K, Grant J, Siniscalchi J, Albertini R. Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics. 2001;42:504-510.
Veale D, Boocock A, Gournay K, et al. Body dysmorphic disorder: a survey of 50 cases. Br J Psychiatry. 1996;169(2):196-201.
Phillips K, Albertini R, Rasmussen S. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59:381-388.
Golden R, Gaynes B, Ekstrom R, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162:656-662.
Kessler R, Berglund P, Demler O, Jin R, Merikangas K, Walters E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602.
Kessler R, Chiu W, Demler O, Merikangas K, Walters E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627.
Williams D, González H, Neighbors H, et al. Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch Gen Psychiatry. 2007;64:305-315.
Robinson R. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry. 2003;54:376-387.
McDonald W, Richard I, DeLong M. Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry. 2003;54:363-375.
Huffman J, Smith F, Blais M, Beiser M, Januzzi J, Fricchione G. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am J Cardiol. 2006;98:319-324.
Reiche E, Nunes S, Morimoto H. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5:617-625.
Wittchen H, Kessler R, Pfister H, Lieb M. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand Suppl. 2000;406:14-23.
Merikangas K, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry. 2003;60:993-1000.
Mahoney J, Drinka T, Abler R, et al. Screening for depression: single question versus GDS. J Am Geriatr Soc. 1994;42:1006-1008.
Arroll B, Khin N, Kerse N. Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ. 2003;327:1144-1146.
Whooley M, Avins A, Miranda J, Browner W. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12:439-445.
Thase M. Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry. 2003;64(13):18-25.
Persad E. Electroconvulsive therapy in depression. Can J Psychiatry. 1990;35(2):175-182.
Keck PJ, McElroy S, Arnold L. Bipolar disorder. Med Clin North Am. 2001;85:645-661.
Benazzi F. Bipolar disorder–focus on bipolar II disorder and mixed depression. Lancet. 2007;369:935-945.
Suppes T, Dennehy E, Gibbons E. The longitudinal course of bipolar disorder. J Clin Psychiatry. 2000;61(9):23-30.
Hilty D, Brady K, Hales R. A review of bipolar disorder among adults. Psychiatr Serv. 1999;50:201-213.
Das A, Olfson M, Gameroff M, et al. Screening for bipolar disorder in a primary care practice. JAMA. 2005;293:956-963.
Hirschfeld R, Williams J, Spitzer R, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry. 2000;157:1873-1875.
American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Part A: Treatment recommendations for patients with bipolar disorder. Am J Psychiatry. 2002;159:1-50.
Drugs for psychiatric disorders. Treat Guide Med Lett. 2006;4(46): 35-46.
Bowden C. Novel treatments for bipolar disorder. Expert Opin Investig Drugs. 2001;10:661-671.
Soloff P, Lis J, Kelly T, Cornelius J, Ulrich R. Risk factors for suicidal behavior in borderline personality disorder. Am J Psychiatry. 1994;151:1316-1323.
Skodol A, Oldham J, Gallaher P. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders. Am J Psychiatry. 1999;156:733-738.
Cadoret R, Leve L, Devor E. Genetics of aggressive and violent behavior. Psychiatr Clin North Am. 1997;20:301-323.
Caspi A, Begg D, Dickson N, et al. Personality differences predict health-risk behaviors in young adulthood: evidence from a longitudinal study. J Pers Soc Psychol. 1997;73:1052-1063.
Gerstley L, McLellan A, Alterman A, Woody G, Luborsky L, Prout M. Ability to form an alliance with the therapist: a possible marker of prognosis for patients with antisocial personality disorder. Am J Psychiatry. 1989;146:508-512.
Markovitz P, Calabrese J, Schulz S, Meltzer H. Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry. 1991;148:1064-1067.
Soloff PH. Symptom-oriented psychopharmacology for personality disorders. J Pract Psychiatry Behav Health. 1998;4:3-11.
Lieb K, Zanarini M, Schmahl C, Linehan M, Bohus M. Borderline personality disorder. Lancet. 2004;364:453-461.
Histrionic personality disorder. Available at: http://www.clevelandclinic.org/health/health-info/docs/3700/3795.asp?index=9743. Accessed November 30, 2007.
Britton R. Narcissistic disorders in clinical practice. J Anal Psychol. 2004;49(4):477-490.
Villemarette-Pittman N, Stanford M, Greve K, Houston R, Mathias C. Obsessive-compulsive personality disorder and behavioral disinhibition. J Psychol. 2004;138(1):5-22.
Fineberg N, Sharma P, Sivakumaran T, Sahakian B, Chamberlain S. Does obsessive-compulsive personality disorder belong within the obsessive-compulsive spectrum? CNS Spectr. 2007;12(6):467-482.
Mancebo M, Eisen J, Grant J, Rasmussen S. Obsessive compulsive personality disorder and obsessive compulsive disorder: clinical characteristics, diagnostic difficulties, and treatment. Ann Clin Psychiatry. 2007;17(4):197-204.
Goodwin R. Anxiety disorders and the onset of depression among adults in the community. Psychol Med. 2002;32:1121-1124.
Brown T, O’Leary T, Barlow D. Generalised Anxiety Disorder. Clinical Handbook of Psychological Disorders: A Step-by-Step Treatment Manual. New York: Guilford; 2001.
Wirt S, Wallace V, Rogalla C. Laser therapy for patients with vascular malformations. Plast Surg Nurs. 1997;17(4):200-204.
Clymer M, Fortune D, Reinisch L, Toriumi D, Werkhaven J, Ries W. Interstitial Nd:YAG photocoagulation for vascular malformations and hemangiomas in childhood. Arch Otolaryngol Head Neck Surg. 1998;124(4):431-436.
Leaute-Labreze C, Boralevi F, Pedespan J, Meymat Y, Taieb A. Pulsed dye laser for Sturge-Weber syndrome. Arch Dis Child. 2002;87(5):434-435.
Hirschfeld R, Williams J, Spitzer R, et al. Development and valiÂdation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry. 2000;157:1873-1875.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Glaser, D.A. (2011). Psychological Aspects to Consider Within Laser Treatments. In: Nouri, K. (eds) Lasers in Dermatology and Medicine. Springer, London. https://doi.org/10.1007/978-0-85729-281-0_32
Download citation
DOI: https://doi.org/10.1007/978-0-85729-281-0_32
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-280-3
Online ISBN: 978-0-85729-281-0
eBook Packages: MedicineMedicine (R0)